# F5 Scoped Adversarial — Convergence Summary

- **Cycle:** cycle-013 (`msrv-1.88-bump`)
- **Phase:** F5 scoped adversarial review
- **Scope:** `git diff 7160a534..b960c305` (46 files, +1073/−1050) — the cycle-013 delta:
  MSRV 1.85→1.88 bump + ~73-site clippy `collapsible_if`→let-chain retrofit (PR #818),
  Wave-2 S3 docs reconciliation (PR #819), Wave-2-gate F-2 doc fix (PR #822).
- **Date:** 2026-09-16

## Verdict: F5 CONVERGED

| Review | Result |
|--------|--------|
| Adversary Pass 1 (fresh context) | CLEAN — 0 CRIT/HIGH/MED |
| Adversary Pass 2 (fresh context, different model family) | CLEAN — 0 CRIT/HIGH/MED |
| Adversary Pass 3 (fresh context, different model family) | CLEAN — 0 CRIT/HIGH/MED |
| Code-reviewer | APPROVE |
| Security-reviewer | CLEAN — 0 findings |

**3 consecutive CLEAN adversary passes** (minimum convergence threshold) + code-review
APPROVE + security CLEAN. **Zero unresolved CRIT/HIGH/MED findings across all five review
artifacts.**

## Novelty assessment

Delta is mechanical: a toolchain-version bump, a clippy-driven syntax-only refactor
(nested-if → let-chain, behavior-preserving at every site), and two documentation
reconciliation PRs. Novelty of findings across all three adversary passes is LOW — no
CRIT/HIGH/MED surfaced at any point in the review sequence; the only findings were
already-tracked LOW/NIT items (historical plandoc MSRV staleness, already covered by the
existing `CYCLE-013-F3-HISTORICAL-PLANDOC-MSRV-MENTIONS` standing item) plus one new LOW
standing item (`CYCLE-013-COMFY-TABLE-ZERO-HEADROOM-MSRV`, a forward-looking maintenance
watch, not a defect).

## Code fixes required: NONE

No CRIT/HIGH/MED findings were produced at any point in F5. `develop` remains unchanged at
`b960c305` — F5 is a review-only phase for this cycle; no fix PR was needed.

## Evidence

- `cycles/cycle-013/phase-f5-adversarial/pass-01.md`
- `cycles/cycle-013/phase-f5-adversarial/pass-02.md`
- `cycles/cycle-013/phase-f5-adversarial/pass-03.md`
- `cycles/cycle-013/phase-f5-adversarial/code-review.md`
- `cycles/cycle-013/phase-f5-adversarial/security-review.md`

## Next

Phase F6 targeted hardening (formal verification / fuzz / mutation testing scoped to the
cycle-013 delta, plus full-tree regression and security scans).
